BACKGROUND: Although calcific aortic stenosis is common, calcification of the other three heart valves is not. The aortic valve interstitial cell (VIC) has been implicated in the pathogenesis of aortic stenosis. Proinflammatory stimulation of aortic VICs induces an osteogenic and inflammatory phenotypic change. We hypothesized that the VICs of the other heart valves do not undergo these changes. Using isolated human VICs from normal aortic, mitral, pulmonary, and tricuspid valves, our purpose was to compare the osteogenic response to proinflammatory stimulation via toll-like receptor 4 (TLR-4). MATERIALS AND METHODS: Aortic, pulmonic, mitral, and tricuspid (n=4 for each valve type) VICs were isolated from hearts valves explanted from patients undergoing cardiac transplantation. Cells were cultured and grown to confluence in passage 2-6 before treatment with Lipopolysaccharide (LPS) (100-200 ng/mL) for 24 or 48 h. Cells were characterized by immunofluorescent staining. TLR-4 expression was analyzed (immunoblotting, flow cytometry). Bone morphogenetic protein 2 and intercellular adhesion molecule 1 production were determined (immunoblotting). Monocyte chemoattractant protein 1 levels were determined by enzyme-linked immunosorbent assay. Statistics were by Mann-Whitney U test. RESULTS: TLR-4 stimulation induced bone morphogenetic protein 2 production only in aortic VICs (P<0.05). Intra-cellular adhesion molecule 1 production and monocyte chemoattractant protein 1 secretion increased in a similar fashion among TLR-4-stimulated VICs from all four valves. CONCLUSIONS: Proinflammatory stimulation induces an osteogenic phenotype in aortic VICs but not mitral, pulmonic, or tricuspid VICs. We conclude that this differential osteogenic response of aortic VICs contributes to the pathogenesis of calcific aortic stenosis.
BACKGROUND: Although calcific aortic stenosis is common, calcification of the other three heart valves is not. The aortic valve interstitial cell (VIC) has been implicated in the pathogenesis of aortic stenosis. Proinflammatory stimulation of aortic VICs induces an osteogenic and inflammatory phenotypic change. We hypothesized that the VICs of the other heart valves do not undergo these changes. Using isolated human VICs from normal aortic, mitral, pulmonary, and tricuspid valves, our purpose was to compare the osteogenic response to proinflammatory stimulation via toll-like receptor 4 (TLR-4). MATERIALS AND METHODS: Aortic, pulmonic, mitral, and tricuspid (n=4 for each valve type) VICs were isolated from hearts valves explanted from patients undergoing cardiac transplantation. Cells were cultured and grown to confluence in passage 2-6 before treatment with Lipopolysaccharide (LPS) (100-200 ng/mL) for 24 or 48 h. Cells were characterized by immunofluorescent staining. TLR-4 expression was analyzed (immunoblotting, flow cytometry). Bone morphogenetic protein 2 and intercellular adhesion molecule 1 production were determined (immunoblotting). Monocyte chemoattractant protein 1 levels were determined by enzyme-linked immunosorbent assay. Statistics were by Mann-Whitney U test. RESULTS:TLR-4 stimulation induced bone morphogenetic protein 2 production only in aortic VICs (P<0.05). Intra-cellular adhesion molecule 1 production and monocyte chemoattractant protein 1 secretion increased in a similar fashion among TLR-4-stimulated VICs from all four valves. CONCLUSIONS: Proinflammatory stimulation induces an osteogenic phenotype in aortic VICs but not mitral, pulmonic, or tricuspid VICs. We conclude that this differential osteogenic response of aortic VICs contributes to the pathogenesis of calcific aortic stenosis.
Authors: Javier López; Isabel Fernández-Pisonero; Ana I Dueñas; Patricia Maeso; J Alberto San Román; Mariano Sánchez Crespo; Carmen García-Rodríguez Journal: Int J Cardiol Date: 2011-01-17 Impact factor: 4.164
Authors: Xianzhong Meng; Lihua Ao; Yong Song; Ashok Babu; Xiaoping Yang; Maorong Wang; Michael J Weyant; Charles A Dinarello; Joseph C Cleveland; David A Fullerton Journal: Am J Physiol Cell Physiol Date: 2007-10-17 Impact factor: 4.249
Authors: Nicole Nadlonek; Joon H Lee; T Brett Reece; Michael J Weyant; Joseph C Cleveland; Xianzhong Meng; David A Fullerton Journal: Ann Thorac Surg Date: 2013-06-02 Impact factor: 4.330
Authors: Xiaoping Yang; David A Fullerton; Xin Su; Lihua Ao; Joseph C Cleveland; Xianzhong Meng Journal: J Am Coll Cardiol Date: 2009-02-10 Impact factor: 24.094
Authors: Dena C Wiltz; Richard I Han; Reid L Wilson; Aditya Kumar; Joel D Morrisett; K Jane Grande-Allen Journal: Cardiovasc Eng Technol Date: 2014-12-01 Impact factor: 2.495
Authors: Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot Journal: Nat Rev Dis Primers Date: 2016-03-03 Impact factor: 52.329
Authors: Olga Irtyuga; Anna Malashicheva; Ekaterina Zhiduleva; Olga Freylikhman; Oxana Rotar; Magnus Bäck; Svetlana Tarnovskaya; Anna Kostareva; Olga Moiseeva Journal: Biomed Res Int Date: 2017-01-26 Impact factor: 3.411
Authors: Carmen García-Rodríguez; Iván Parra-Izquierdo; Irene Castaños-Mollor; Javier López; J Alberto San Román; Mariano Sánchez Crespo Journal: Front Physiol Date: 2018-03-12 Impact factor: 4.566